Skip to content
★ Sign in to follow
GS

Gregg S. Sutton

Surmodics IncVascular Solutions Inc
Total declarations
20
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€952k

Latest filing published 02 Dec 2019 for Surmodics INC, €15k.

Filing timeline

BuySale
Gregg S. Sutton

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

Gregg S. Sutton: trading record in brief

Gregg S. Sutton discloses dealings in 2 companies, chiefly Surmodics Inc and Vascular Solutions Inc. In total, 20 filings cover trades dated from 25 January 2006 to 30 November 2019.

No open-market purchase appears, only 2 sales worth €952k. Outside the open market, there are 16 share grants and 2 option exercises.

Most recently, on 2 December 2019, the filings show a share grant worth €26k in Surmodics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Gregg S. Sutton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    16,479 USD11SEC
    403 shares@ US$40.890.9% of flowCommon StockSEC:0001209191-19-058519:0
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    28,091 USD11SEC
    687 shares@ US$40.891.5% of flowCommon StockSEC:0001209191-19-058519:1
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    16,950 USD11SEC
    413 shares@ US$41.040.9% of flowCommon StockSEC:0001209191-19-058519:2
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    0SEC
    7,852 shares0Common StockSEC:0001209191-19-058310:0
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    0SEC
    1,904 shares0Common StockSEC:0001209191-19-058310:2
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    0SEC
    3,571 shares0Common StockSEC:0001209191-19-058310:3
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    150,402 USD12SEC
    3,581 shares@ US$42.008.1% of flowCommon StockSEC:0001209191-19-058310:1
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    25,024 USD11SEC
    413 shares@ US$60.591.3% of flowCommon StockSEC:0001209191-18-060865:0
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    234,561 USD12SEC
    4,142 shares@ US$56.6312.3% of flowCommon StockSEC:0001209191-18-060231:2
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    41,261 USD11SEC
    687 shares@ US$60.062.2% of flowCommon StockSEC:0001209191-18-060231:3
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    0SEC
    2,648 shares0Common StockSEC:0001209191-18-060231:0
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    0SEC
    9,083 shares0Common StockSEC:0001209191-18-060231:1
  • ◇
    VP of Research and DevelopmentExecutivesSurmodics Inc
    204,764 USD12SEC
    10,544 shares@ US$19.4210.5% of flowCommon StockSEC:0001209191-18-048513:0
  • ◇
    VP of Research and DevelopmentExecutivesSurmodics Inc
    102,506 USD12SEC
    4,280 shares@ US$23.955.3% of flowCommon StockSEC:0001209191-18-048513:1
  • ▼
    VP of Research and DevelopmentExecutivesSurmodics Inc
    1M USD34SEC
    14,204 shares@ US$74.1154.0% of flowCommon StockSEC:0001209191-18-048513:2
  • ▼
    VP of Research and DevelopmentExecutivesSurmodics Inc
    46,463 USD29SEC
    620 shares@ US$74.942.4% of flowCommon StockSEC:0001209191-18-048513:3
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    0SEC
    4,518 shares0Common StockSEC:0001209191-17-063126:0
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    14,432 USD11SEC
    436 shares@ US$33.100.7% of flowCommon StockSEC:0001209191-17-063126:1
  • ◆
    VP of Research and DevelopmentExecutivesSurmodics Inc
    0SEC
    2,713 shares0Common StockSEC:0001209191-16-153171:0
  • ◆
    VP R&DExecutivesVascular Solutions Inc
    0SEC
    10,000 sharesCommon StockSEC:0000897101-06-000207:0

20 of 20 declarations